NAD⁺ Therapeutics and Skeletal Muscle Adaptation to Exercise in Humans.

"Declarations FundingThis article is based on a presentation by Andrew Philp to the GSSI Expert Panel Virtual Meeting in October 2021. An honorarium for preparation of this article was provided by the GSSI. Andrew Philp also acknowledges funding from the National Health and Medical Research Council and the Rebecca Cooper Medical Research Foundation. Conflicts of Interest/Competing InterestsDean Campelj and Andrew Philp have no conflicts of interest that are directly relevant to the content of this review. Ethics ApprovalNot applicable. Consent to ParticipateNot applicable. Consent for PublicationNot applicable. Availability of Data and MaterialNot applicable. Code Availability Not applicable. Authors’ ContributionsBoth DC and AP devised, wrote, and edited the manuscript, and approved the final version of the manuscript prior to submission. Both authors read and approved the final manuscript. Conflicts of Interest/Competing Interests Dean Campelj and Andrew Philp have no conflicts of interest that are directly relevant to the content of this review."

"Funding This article is based on a presentation by Andrew Philp to the GSSI Expert Panel Virtual Meeting in October 2021. An honorarium for preparation of this article was provided by the GSSI. Andrew Philp also acknowledges funding from the National Health and Medical Research Council and the Rebecca Cooper Medical Research Foundation."